KD025 (SLx-2119)
99%
- Product Code: 66564
CAS:
911417-87-3
| Molecular Weight: | 452.51 g./mol | Molecular Formula: | C₂₆H₂₄N₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD23098791 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
KD025 (SLx-2119) is primarily used in the field of medical research and therapeutics, particularly as a selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2). Its application is significant in the study and treatment of various diseases, including autoimmune disorders, fibrotic diseases, and certain types of cancer. By targeting ROCK2, it modulates immune responses and reduces inflammation, making it a potential candidate for conditions like psoriasis, rheumatoid arthritis, and chronic graft-versus-host disease. Additionally, its antifibrotic properties are being explored for treating liver fibrosis and idiopathic pulmonary fibrosis. In oncology, KD025 is investigated for its role in inhibiting tumor growth and metastasis by affecting signaling pathways involved in cancer progression. Its therapeutic potential continues to be evaluated in clinical trials, aiming to provide new treatment options for these complex diseases.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to yellow Solid |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $216.02 |
+
-
|
| 0.025 | 10-20 days | $500.45 |
+
-
|
| 0.100 | 10-20 days | $1,110.11 |
+
-
|
| 0.500 | 10-20 days | $2,535.25 |
+
-
|
KD025 (SLx-2119)
KD025 (SLx-2119) is primarily used in the field of medical research and therapeutics, particularly as a selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2). Its application is significant in the study and treatment of various diseases, including autoimmune disorders, fibrotic diseases, and certain types of cancer. By targeting ROCK2, it modulates immune responses and reduces inflammation, making it a potential candidate for conditions like psoriasis, rheumatoid arthritis, and chronic graft-versus-host disease. Additionally, its antifibrotic properties are being explored for treating liver fibrosis and idiopathic pulmonary fibrosis. In oncology, KD025 is investigated for its role in inhibiting tumor growth and metastasis by affecting signaling pathways involved in cancer progression. Its therapeutic potential continues to be evaluated in clinical trials, aiming to provide new treatment options for these complex diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :